RBC Capital analyst Shagun Singh upgraded Teleflex (TFX) to Outperform from Sector Perform with a price target of $155, up from $135. The firm says the company is making progress towards its business transformation. The incoming CEO brings “proven MedTech growth leadership” while Teleflex’s interventional growth should accelerate beginning in the second half of 2026, the analyst tells investors in a research note. RBC adds that the company’s divestitures are on track, unlocking $1.8B in shareholder value.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TFX:
